Home › Funds › CAMPBELL NEWMAN ASSET MANAGEMENT INC › HALO

CAMPBELL NEWMAN ASSET MANAGEMENT INC position in HALO

HALOZYME THERAPEUTICS INC · Health Care

CAMPBELL NEWMAN ASSET MANAGEMENT INC reported holding 38,981 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.3M, representing 0.32% of its reported portfolio and ranking #39 among its reported holdings. CAMPBELL NEWMAN ASSET MANAGEMENT INC has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)38.98K sh
Reported value held$4.30M
Portfolio Weight0.32%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAMPBELL NEWMAN ASSET MANAGEMENT INC's HALO position evolved

CAMPBELL NEWMAN ASSET MANAGEMENT INC first disclosed a stake in HALO in Q3 2023 at 34,061 shares (US$1.3M). The position peaked in Q3 2026 at 38,981 shares, worth US$4.3M. Across 13 filings, CAMPBELL NEWMAN ASSET MANAGEMENT INC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 38,981 shares valued at US$4.3M — an increase of 1,207 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 34.06K $1.30M New
Q4 2023 33.55K $1.24M Reduce
Q1 2024 35.04K $1.43M Add
Q2 2024 35.13K $1.84M Hold
Q3 2024 34.56K $1.98M Reduce
Q4 2024 34.37K $1.64M Reduce
Q1 2025 34.29K $2.19M Hold
Q2 2025 36.73K $1.91M Add
Q3 2025 36.88K $2.70M Hold
Q4 2025 35.53K $2.39M Reduce
Q1 2026 36.13K $2.34M Add
Q2 2026 37.77K $2.96M Add
Q3 2026 38.98K $4.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HALO and 13F data

HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$178.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HALO

All HALO fund holders →

FAQ

How long has CAMPBELL NEWMAN ASSET MANAGEMENT INC held HALO?

CAMPBELL NEWMAN ASSET MANAGEMENT INC has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAMPBELL NEWMAN ASSET MANAGEMENT INC's current position in HALO?

As of Q3 2026, CAMPBELL NEWMAN ASSET MANAGEMENT INC holds 38.98K shares of HALO (HALOZYME THERAPEUTICS INC), valued at $4.30M, representing 0.32% of its reported portfolio and ranking #39.

Has CAMPBELL NEWMAN ASSET MANAGEMENT INC been buying or selling HALO?

In the latest 13F filing (Q3 2026), CAMPBELL NEWMAN ASSET MANAGEMENT INC increased its position in HALO. The position peaked in Q3 2026 at 38.98K shares.

Which other funds hold HALO?

Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, SNYDER CAPITAL MANAGEMENT L P, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.